Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Rosuvastatin 5mg launched

Rosuvastatin (Crestor) has been launched in a 5mg strength. This tablet is half the strength of the previous lowest strength. It is licensed as a starting dose and priced at the same level as the 10mg tablet - £18.03 for 28 tablets.

The new lower dose is intended for use as a start dose in patients who are predisposed to myopathy and Asian patients. Predisposing factors include:

  • Renal Impairment
  • Hypothyroidism
  • Personal or family history of hereditary muscular disorders
  • Previous history of muscular toxicity with other statins or fibrates
  • Alcohol abuse
  • Age over 70 years
  • Situations where an increase in plasma levels may occur
  • Concomitant use of fibrates

Action: Currently, there are no trial data for Rosuvastatin demonstrating a reduction in mortality or morbidity. This level of evidence is available for other statins e.g. Simvastatin. Rosuvastatin is not currently on the formulary. Prescribers who insist on using Rosuvastatin should be aware of the availability of this new dose and indications.

Share 'Rosuvastatin 5mg launched' on Email Share 'Rosuvastatin 5mg launched' on Delicious Share 'Rosuvastatin 5mg launched' on Digg Share 'Rosuvastatin 5mg launched' on Facebook Share 'Rosuvastatin 5mg launched' on Google+ Share 'Rosuvastatin 5mg launched' on reddit Share 'Rosuvastatin 5mg launched' on StumbleUpon Share 'Rosuvastatin 5mg launched' on Twitter

atomic-wealth

No Comments to “Rosuvastatin 5mg launched”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,518 spam comments.

atomic-wealth
fond-illness
summer